Search results

Real Chemistry is a global healthcare communications network and partner to biotechs at every stage of commercialization, from early value creation to launch and beyond. Combining scientific expertise, data and AI‑driven insights, we help ideas break through scientifically and succeed commercially.

Tepthera is a spin off from the ETH Zurich focusing on product development in the field of cancer immunotherapy, autoimmune- and infectious diseases.

Rivia is a unified data and AI analytics platform for biotech clinical trials. Rivia integrates fragmented trial data and turns it into actionable insights, to drive more predictable operations and unlock hidden therapeutic potential. Know Better. Act Better.

The state of the art research complex based in Schlieren, Switzerland, is now an integral part of Roche Pharma Research and Early Development. Roche Innovation Center Zurich focuses on product development – from scientific concepts and validation to the corresponding studies.

Salvina Therapeutics is developing antibodies with a novel approach for targeting TNF and TNF superfamily members with the aim of improving their safety and efficacy, and facilitating the generation of novel bispecific therapies.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. The Bioprocess Solutions Devision, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidl

Securecell is an innovator for both the biotech and medtech space. Developing use-case applications for automated bioprocessing and smart pharmacoligical facilities, as well as the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems.

DiNAMIQS is a leading, science-driven end to end CDMO for AAV and Lentiviruses with a brand new GMP facility in Schlieren/ Zurich for up to 1000L manufacturing up to commercial including fill & finish.

We are specialists for laboratory consumables and pipette service – with a focus on liquid handling. We combine our expertise with a consultative approach so that we can fully understand the daily work of scientists and researchers in order to provide any support needed.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Superlab Suisse provides innovatively designed laboratory facilities and state-of-the-art equipment as well as professional and concierge services and funding support for companies working in biotech, pharma and medtech.

Swiss Bioscience was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce SVF which is then purified and expanded to produce hADSCs.

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.

Switzerland Global Enterprise (S-GE) links companies, experts and public organisations globally, thus facilitating efficient promotion of foreign trade. Apart from export promotion, S-GE is responsible for promoting Switzerland as a business location abroad.

SYDRA AG (Zurich) is a longevity biotech using a phenotype-first, AI-assisted “Hit-to-Target” early drug discovery platform. We discover small molecules (geroprotectors), validate in vivo (worms – aged mice), then map MoA to build partner-ready drug assets; plus science-backed supplements.

The only true end-to-end solutions organization combining clinical and commercialization capabilities with the most advanced science, business and data technologies to drive real advances. We help improve performance, reduce risk and expedite delivery of healthcare innovation to patients worldwide.

Synple Chem was founded to develop new easy to use automated laboratory equipment for chemistry research labs.

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

therainnova AG provides strategic and operational regulatory affairs consulting for the biopharmaceutical industry in Europe. With expert leadership and a strong partner network, we offer end-to-end regulatory support, including due diligence, to maximize portfolio value.

Topadur Pharma AG (Schlieren, Zurich) is a clinical-stage biotech company developing small-molecule therapies that target impaired microcirculation and tissue regeneration. Its proprietary DualTOP® platform combines complementary pharmacological activities in single molecules for local use.

TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.

Ultimate Medicine is a Swiss preclinical biotech focused on preserving independence and quality of life for patients with Alzheimer's disease and other dementias.

VACCENTIS AG is a Zurich-based investment company focused on the biotech and pharmaceutical sector. The entire research, production and sales activities are carried out by two highly specialized subsidiaries, VCC MEDICAL and FBM-Pharma, which focus on special methods of personalized medicine.

Venture Valuation specializes in independent assessments and valuations of companies and products, in biotech and life sciences, and runs the business development database Biotechgate with global licensing deals, and opportunities. To learn more: www.biotechgate.com and Biotechgate Digital Partnering: www.dig

Toolpoint for Lab Science is a vertically integrated cluster that brings together the skills and expertise of the laboratory automation industry in Europe. It brings together companies, universities, research institutes and partners with the aim of making lab processes more effective and efficient.

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

A dynamic presence in the market – with around 240 legal experts and six locations in all language regions, Walder Wyss is one of the most successful law firms in Switzerland. Continuous growth, dedication and proximity to our clients determine our success.

Watson-Marlow is a specialist manufacturer of pumps and tubing, fluid path components and single-use technology for GMP regulated industries. A portfolio of products and assembly design capabilities allows WMFTS to provid accuracy, reliability, and sterility in all fluid handling applications.

WittKieffer is a top 10 executive search and leadership advisory firm exclusively specialised in life sciences organizations operating at the intersection of academia, science, and healthcare.

Wyss Zurich is a joint accelerator of ETH & University of Zurich. Our mission is to drive the clinical translation of outstanding scientific discoveries into new therapies for patients and innovations in the fields of regenerative medicine and robotics, and hybrid technologies in these fields.

Xlife Sciences is a publicly listed life sciences incubator and accelerator. Xlife is focused on the value development and commercialization of promising research projects from universities and other research institutions. The goal is to bridge research and development to healthcare markets.